“Magnitude of clinical benefit” of solid tumour drugs and their real-world application in the Austrian health care setting

•clinical benefit assessment of recently approved cancer drugs via the ESMO-MCBS.•analyses of cancer treatments included in the Austrian hospital benefit catalogue.•application of ESMO-MCBS assessed cancer drugs in the public inpatient sector.•overview of most frequently applied cancer treatments in the Austrian inpatient sector.